Neuroprotection refers to the relative preservation of neuronal structure and function.
Neuroprotective agents refer to substances that are capable of preserving brain function and …

Neurodegenerative disorders are one of the leading causes of death among the elderly.
Therapeutic approaches with a single target have proven unsuccessful in treating these …

Parkinson's disease (PD) is considered one of the health problems in the aging society. Due
to the limitations of currently available drugs in preventing disease progression, the …

Neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, and
Huntington's disease affect millions of people in the world. Thus several new approaches to …

Parkinson's disease (PD) is a slowly progressive and complex neurodegenerative disorder.
Up to date, there are no approved drugs that could slow or reverse the neurodegenerative …

Parkinson's disease is a huge burden in modern medicinal practice. A serious drawback of
current antiparkinsonian therapy is its symptomatic nature. This directed our investigations in …

Parkinson's disease (PD) is an age-related neurodegenerative ailment that affects
dopamine-producing neurons in a specific area of the brain called the substantia nigra of the …

Parkinson's disease (PD) is a complex neurodegenerative disorder with multifactorial
pathologies, including progressive loss of dopaminergic (DA) neurons, oxidative stress …

To discover novel multifunctional agents for the treatment of Parkinson's disease, a series of
2-hydroxyl-4-benzyloxybenzyl aniline derivatives was designed, synthesized and evaluated …

Background Due to the global increase in aging populations and changes in modern
lifestyles, the prevalence of neurodegenerative diseases, cerebrovascular disorders …